Überwachungskoloskopie bei Colitis ulcerosain Deutschland

Zusammenfassung

Berichte von Betroffenen und Ärzten haben die Vermutung entstehen lassen, dass in Deutschland Überwachungskoloskopien zur Karzinomprävention bei Colitis ulcerosa (Cu) selten leitliniengerecht vorgenommen werden. Eine Umfrage der Selbsthilfeorganisation Deutsche Morbus Crohn/Colitis ulcerosa Vereinigung e. V. (DCCV) unter Mitgliedern, die zu den Risikogruppen mit entsprechender Ausbreitung der Colitis ulcerosa und Krankheitsdauer gehören, hat diese Vermutung für die Zahl der bei der Koloskopie genommenen Biopsien bestätigt. Nur bei 9,2 % der Risikopatienten erfolgte eine leitlinienkonforme Koloskopie und bei über 50 % der Risikopatienten wurden weniger als 10 Biopsien genommen.

Abstract

It has been assumed that cancer surveillance colonoscopy in patients with ulcerative colitis is not conducted according to the guidelines in Germany. An inquiry of the self-help organisation German Crohn’s Disease/Ulcerative Colitis Association (DCCV) among organisation members belonging to colorectal cancer risk groups confirmed that the number of biopsies taken during colonoscopy is less than that proposed by the guidelines. Only with 9.2 % of the risk group did a guideline-conformal colonoscopy take place. In more than 50 % of the cases less than 10 biopsies were taken.

Schlüsselwörter

Colitis ulcerosa - chronisch entzündliche Darmerkrankung - Koloskopie - Prävention - Kolonneoplasie

Key words

ulcerative colitis - chronic inflammatory bowel disease - colonoscopy - prevention - colon neoplasms

Literatur

• 1 Eaden J A, Abrams K R, Mayberry J F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis.  Gut. 2001;  48 (4) 526-535
• 2 Chambers W M, Warren B F, Jewell D P. et al . Cancer surveillance in ulcerative colitis.  Br J Surg. 2005;  92 (8) 928-936
• 3 Ekbom A, Helmick C, Zack M. et al . Ulcerative colitis and colorectal cancer. A population-based study.  N Engl J Med. 1990;  323 (18) 1228-1233
• 4 Rubin C E, Haggitt R C, Burmer G C. et al . DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis.  Gastroenterology. 1992;  103 (5) 1611-1620
• 5 Zack M M, Ekbom A, Persson P G. et al . Evaluation of surveillance programmes for colorectal cancer in ulcerative colitis patients by case-control studies: methodological considerations.  J Med Screen. 1997;  4 (3) 137-141
• 6 Choi P M, Nugent F W, Schoetz Jr D J. et al . Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis.  Gastroenterology. 1993;  105 (2) 418-424
• 7 Connell W R, Talbot I C, Harpaz N. et al . Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis.  Gut. 1994;  35 (10) 1419-1423
• 8 Karlen P, Kornfeld D, Brostrom O. et al . Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study.  Gut. 1998;  42 (5) 711-714
• 9 Rutter M D, Saunders B P, Wilkinson K H. et al . Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis.  Gastroenterology. 2006;  130 (4) 1030-1038
• 10 Lindberg J, Stenling R, Palmqvist R. et al . Efficiency of colorectal cancer surveillance in patients with ulcerative colitis: 26 years’ experience in a patient cohort from a defined population area.  Scand J Gastroenterol. 2005;  40 (9) 1076-1080
• 11 Schmiegel W, Pox C, Kroesen A. Colitis ulcerosa. Karzinomprophylaxe.  Z Gastroenterol. 2004;  42 (9) 1014-1018
• 12 Hoffmann R M, Kruis W. Chronisch-entzündliche Darmerkrankungen. Sauerbruch T, Scheurlen CH Empfehlungen der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) für die Durchführung endoskopischer Untersuchungen, 3. Auflage Stuttgart; Demeter 2002: 135-147
• 13 Winawer S, Fletcher R, Rex D. et al . Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.  Gastroenterology. 2003;  124 (2) 544-560
• 14 Kornbluth A, Sachar D B. Practice Parameters Committee of the American College of Gastroenterology . Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee.  Am J Gastroenterol. 2004;  99 (7) 1371-1385
• 15 Eaden J A, Mayberry J F. British Society for Gastroenterology; Association of Coloproctology for Great Britain and Ireland . Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.  Gut. 2002;  51 (Suppl 5) V10-12
• 16 New Zealand Guidelines Group (NZGG) .Surveillance and management of groups at increased risk of colorectal cancer. Wellington; Mai 2004 www. nzgg.org.nz
• 17 Itzkowitz S H, Present D H. Crohn’s and Colitis Foundation of America Colon Cancer in IBD Study Group . Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease.  Inflamm Bowel Dis. 2005;  11 (3) 314-321
• 18 Hudson B, Green J. British Society of Gastroenterology guidelines for ulcerative colitis surveillance: creating consensus or confusion?.  Gut. 2006;  55 (7) 1052-1053
• 19 Obrador A, Ginard D, Barranco L. Review Article: Colorectal cancer surveillance in ulcerative colitis - what should we be doing?.  Aliment Pharmacol Ther. 2006;  24 (Suppl 3) 56-63
• 20 Eaden J A, Ward B A, Mayberry J F. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance.  Gastrointest Endosc. 2000;  51 (2) 123-128
• 21 Gearry R B, Wakeman C J, Barclay M L. et al . Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand.  Dis Colon Rectum. 2004;  47 (3) 314-322
• 22 Bernstein C N, Weinstein W M, Levine D S. et al . Physicians’ perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis.  Am J Gastroenterol. 1995;  90 (12) 2106-2114
• 23 Timmer A, Bauer A, Bokhof B. et al . Sexual Function in Men with IBD - a survey with controls.  DDW. 2006, ID# W1046; 
• 24 Raspe H, Muche-Borowski C. Versorgungsnetze für CED-Kranke - KN Chronisch entzündliche Darmerkrankungen (KN-CED). BMBF Von der Forschung in die Versorgung - Kompetenznetze in der Medizin Berlin; BMBF 2006: 37-38
• 25 Delco F, Sonnenberg A. A decision analysis of surveillance for colorectal cancer in ulcerative colitis.  Gut. 2000;  46 (4) 500-506
• 26 Provenzale D, Gray R N. Colorectal cancer screening and treatment: review of outcomes research.  J Natl Cancer Inst Monogr. 2004;  33 45-55
• 27 Kiesslich R, Fritsch J, Holtmann M. et al . Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.  Gastroenterology. 2003;  124 (4) 880-888
• 28 Rutter M D, Saunders B P, Schofield G. et al . Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis.  Gut. 2004;  53 (2) 256-260
• 29 Tanaka S, Oka S, Hirata M. et al . Pit pattern diagnosis for colorectal Neoplasia using narrow band imaging magnification.  Digestive Endoscopy. 2006;  18 (Suppl 1) S52-S56
• 30 Messmann H, Endlicher E, Freunek G. et al . Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic acid sensitisation.  Gut. 2003;  52 (7) 1003-1007
• 31 Ochsenkuhn T, Tillack C, Stepp H. et al . Low frequency of colorectal dysplasia in patients with long-standing inflammatory bowel disease colitis: detection by fluorescence endoscopy.  Endoscopy. 2006;  38 (5) 477-482
• 32 Kiesslich R, Hoffman A, Goetz M. et al . In vivo diagnosis of collagenous colitis by confocal endomicroscopy.  Gut. 2006;  55 (4) 591-592
• 33 Holzmann K, Weis-Klemm M, Klump B. et al . Comparison of flow cytometry and histology with mutational screening for p53 and Ki-ras mutations in surveillance of patients with long-standing ulcerative colitis.  Scand J Gastroenterol. 2001;  36 (12) 1320-1326
• 34 Rex D K, Petrini J L, Baron T H. et al . ASGE/ACG Taskforce on Quality in Endoscopy. Quality indicators for colonoscopy.  Am J Gastroenterol. 2006;  101 (4) 873-885
• 35 Rutter M D, Saunders B P, Wilkinson K H. et al . Intangible Costs and Benefits of Ulcerative Colitis Surveillance: A Patient Survey.  Dis Colon Rectum. 2006;  49 (8) 1177-1183